1.Effect of implementing humanised care in a rehabilitation ward
Lirong ZHONG ; Rongbing KONG ; Sufang HUANG
Chinese Journal of Rehabilitation Theory and Practice 2008;14(4):392-393
Objective To observe the effect of humanistic nursing care in rehabilitation ward.Methods 440 inpatients in rehabilitation ward were randomly divided into the observation group(228 cases,treated with humanistic nursing)and control group(212 cases,treated with traditional nursing).40 cases in each group received the investigation of patients' satisfaction to the service.Results The satisfactory rate of the patients in the control group to the attitude of the service,the nursing skill and health education missionary were 72.5%,75% and 67.5% respectively,but that of the patients in the observation group were all 100%,there was a significant difference between two groups(P<0.01).Conclusion Humanistic nursing care in rehabilitation ward can improve nursing qualification and increase patients' satisfactory rate.
2.Changing resistance proifle ofProteus, Serratia, Citrobacter, Morganella andProvidencia isolates in hospitals across China:data from CHINET Antimicrobial Resistance Surveillance Program 2005-2014
Jin LI ; Zhidong HU ; Fu WANG ; Demei ZHU ; Fupin HU ; Ziyong SUN ; Zhongju CHEN ; Yi XIE ; Mei KANG ; Yingchun XU ; Xiaojiang ZHANG ; Zhaoxia ZHANG ; Ping JI ; Chuanqing WANG ; Aimin WANG ; Yuxing NI ; Jingyong SUN ; Yunsong YU ; Jie LIN ; Yunzhuo CHU ; Sufei TIAN ; Yuanhong XU ; Jilu SHEN ; Bin SHAN ; Yan DU ; Chao ZHUO ; Danhong SU ; Hong ZHANG ; Jing KONG ; Lianhua WEI ; Ling WU ; Yunjian HU ; Xiaoman AI ; Yanqiu HAN ; Sufang GUO ; Qing YANG ; Bei JIA ; Wenxing HUANG
Chinese Journal of Infection and Chemotherapy 2016;16(3):284-293
Objective To understand the changing resistance proifle ofProteus,Serratia,Citrobacter,Morganella andProvidencia in hospitals across China according to the data from CHINET Antimicrobial Resistance Surveillance Program 2005-2014.Methods Antimicrobial susceptibility was tested by using Kirby-Bauer method or automatic minimum inhibitory concentration determination according to a uniifed protocol.Results A total of 21 663 clinical isolates were collected from January 2005 to December 2014. The proportion ofProteus andSerratia isolates increased with time from 1.41% in 2005 to 2.09% in 2014, and from 0.99% in 2005 to 1.28% in 2014 among all the isolates. No change was found for the proportion ofCitrobacter,Morganella, orProvidencia. Less than 10% of theProteus isolates were resistant to cefoperazone-sulbactam, piperacillin-tazobactam, ceftazidime, cefoxitin, amikacin and tigecycline. Less than 10% of theSerratia isolates were resistant to cefoperazone-sulbactam, piperacillin-tazobactam, amikacin and tigecycline. Less than 20% of theCitrobacter isolates were resistant to cefoperazone-sulbactam, piperacillin-tazobactam, cefepime, amikacin and tigecycline. Less than 10% of theMorganella isolates were resistant to cefoperazone-sulbactam, piperacillin-tazobactam, cefepime, amikacin and tigecycline. Less than 20% of theProvidencia isolates were resistant to cefoperazone-sulbactam, piperacillin-tazobactam, cefepime, cefoxitin and tigecycline.Conclusions The antibiotic resistance ofProteus,Serratia, Citrobacter,Morganella andProvidencia isolates in hospitals across China is growing during the period from 2005 to 2014. Strengthening infection control and rational antibiotic use are effective to slow the growth of drug resistance.
3.Antibiotic resistance profile of Enterobacter in hospitals across China:data from CHINET Antimicrobial Resistance Surveillance Program from 2005 through 2014
Lei TIAN ; Zhongju CHEN ; Ziyong SUN ; Yingchun XU ; Xiaojiang ZHANG ; Yuxing NI ; Jingyong SUN ; Fu WANG ; Demei ZHU ; Yuanhong XU ; Jilu SHEN ; Hong ZHANG ; Jing KONG ; Qing YANG ; Lianhua WEI ; Ling WU ; Zhidong HU ; Jin LI ; Chuanqing WANG ; Aimin WANG ; Chao ZHUO ; Danhong SU ; Yi XIE ; Mei KANG ; Bin SHAN ; Yan DU ; Zhaoxia ZHANG ; Ping JI ; Yunjian HU ; Xiaoman AI ; Yunzhuo CHU ; Sufei TIAN ; Bei JIA ; Wenxiang HUANG ; Yunsong YU ; Jie LIN ; Yanqiu HAN ; Sufang GUO
Chinese Journal of Infection and Chemotherapy 2016;16(3):275-283
Objective To investigate the distribution and antibiotic resistance proifle of clinicalEnterobacter isolates using the data from CHINET during the period from 2005 through 2014.Methods A total of 20 558 clinical strains ofEnterobacter spp. were collected from 2005 to 2014 in CHINET Antimicrobial Resistance Surveillance Program. Antimicrobial susceptibility testing was performed with Kirby-Bauer or minimum inhibitory concentration method. The results were analyzed according to CLSI 2014 breakpoints.ResultsEnterobacter cloacae andEnterobacter aerogenes accounted for 71.1% (14 617/20558) and 20.1% (4 129/20 558) of all theEnterobacterisolates, respectively. The proportion ofEnterobacter spp. increased with time from 3.5% in 2005 to 4.3% in 2014. The main source of the isolates was respiratory tract, accounting for 55.2% (11 358/20 558). More than 90% of theEnterobacterisolates were resistant to cefazolin and cefoxitin, but less than 30% of the strains were resistant to cefepime, piperacillin-tazobactam, cefoperazone-sulbactam, amikacin, gentamicin, ciprolfoxacin, meropenem, imipenem and ertapenem. TheEnterobacterisolates showed a trend of declining resistance to most antibiotics except ertapenem and meropenem. The resistance proifle ofEnterobacterisolates varied with departments where they were isolated. The strains from ICU and Department of Surgery were relatively more resistant to antibiotics. The prevalence of multi-drug resistant (MDR) strains was decreasing, but the prevalence of carbapenem-resistantEnterobacter (CRE, resistant to any of imipenem, meropenem or ertapenem) was increasing. The MDR and CRE strains were primarily isolated from ICU and Department of Surgery. At least 30% of the MDREnterobacter strains were resistant to any of the antimicrobial agents tested except meropenem, imipenem and ertapenem and at least 35% of the CRE strains were resistant to any of the antimicrobial agents tested except amikacin and ciprolfoxacin.Conclusions TheEnterobacter isolates in CHINET Antimicrobial Resistance Surveillance Program showed decreasing resistance to most of the antimicrobial agents tested since 2011, but the prevalence of CRE strains increased progressively. Effective measures should be carried out to prevent the spread of CRE strains in hospitals.
4.Changing susceptibility ofKlebsiella strains in hospitals across China:data from the CHINET Antimicrobial Resistance Surveillance Program, 2005-2014
An XU ; Chao ZHUO ; Danhong SU ; Fupin HU ; Demei ZHU ; Fu WANG ; Xiaofei JIANG ; Yingchun XU ; Xiaojiang ZHANG ; Ziyong SUN ; Zhongju CHEN ; Yuxing NI ; Jingyong SUN ; Zhidong HU ; Jin LI ; Zhaoxia ZHANG ; Ping JI ; Chuanqing WANG ; Aimin WANG ; Qing YANG ; Yuanhong XU ; Jilu SHEN ; Bin SHAN ; Yan DU ; Hong ZHANG ; Jing KONG ; Lianhua WEI ; Ling WU ; Yi XIE ; Mei KANG ; Yunjian HU ; Xiaoman AI ; Yunsong YU ; Jie LIN ; Wenxiang HUANG ; Bei JIA ; Yunzhuo CHU ; Sufei TIAN ; Yanqiu HAN ; Sufang GUO
Chinese Journal of Infection and Chemotherapy 2016;16(3):267-274
Objective To evaluate the changing pattern of antibiotic resistance inKlebsiella strains isolated from the patients in 19 hospitals across China based on the data from CHINET Antimicrobial Resistance Surveillance Program during the period from 2005 through 2014.Methods Kirby-Bauer disk diffusion and automated susceptibility testing methods were used to test the susceptibility ofKlebsiella isolates to the commonly used antibiotics. The results were interpreted according to the criteria of the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing (CLSI-2014).Results A total of 61 406Klebsiella strains were identified between 2005 and 2014, includingK. pneumoniae (56 281 strains), K. oxytoca(4 779),Klebsiella pneumoniae subsp.Ozaenae (300) and otherKlebsiella species (46). Most (89.0%, 54 664/61 406) of theKlebsiella strains were isolated from inpatients, and 60.0% (36 835/61 406) were from respiratory tract speciems. About 16.7% (10 248/61 406) of the strains were isolated from pediatric patients aged 0-17 years and 83.3% (51 158/61 406) from adult patients. The prevalence ofKlebsiella spp. increased with time from 10.1% in 2005 to 14.3% in 2014. Based on the surveillance data during the 10-year period, we found a marked increase of resistance to imipenem (2.9% to 10.5%) and meropenem (2.8% to 13.4%) inKlebsiella spp. The prevalence of ESBLs-producing isolates inK. pneumoniae andK. oxytoca decreased from 39.0% in 2005 to 30.1% in 2014. The resistance to amikacin, ceftazidime, ciprolfoxacin, pipracillin-tazobactam and cefoperazone-sulbactam was on decline. The resistance rate to cefotaxime remained high about 49.5%. Carbapenem resistantance was identiifed in 5 796 (9.4%) of the isolates, including 5 492 strains ofK. pneumoniae and 280 strains ofK. oxytoca. Overall, 4 740 (7.8%) strains were identiifed as extensively-drug resistant (XDR), including 4 520 strains ofK. pneumoniae and 202 strains ofK. oxytoca. The carbapenem-resistant strains showed high (>60%) resistance rate to majority of the antimicrobial agents tested, but relatively low resistance to tigecycline (16.8%), amikacin (54.4%), and trimethoprim-sulfamethoxazole (55.5%).Conclusions During the 10-year period from 2005 through 2014, carbapenem resistance amongKlebsiella isolates has increased dramatically in the hospitals across China. The level of resistance to other antibiotics remains stable.
5.Current situation of incision sites in laparoscopic nephrectomy for intact specimens by urologists in China
Sufang KONG ; Nan ZHANG ; Yaohui MA ; Qingjun GUAN ; Xiangrui LI ; Zhongjie SHAN
Journal of Modern Urology 2023;28(2):153-156
【Objective】 To investigate the current status of incision sites to obtain intact specimens in laparoscopic nephrectomy by urologists in China, so as to provide reference for the standardized procedure. 【Methods】 During Jun.20, 2021 and Jul.4, 2021, more than 20 000 urologists in a WeChat group were surveyed with a questionnaire. The general data, incision sites and related complications were statistically analyzed. 【Results】 A total of 601 valid questionnaires were collected, covering urologists from 31 provinces, autonomous regions and municipalities. Surgical approaches: 68 urologists chose trans-abdominal approach, 432 chose posterior abdominal space approach, 101 chose both surgical approaches. Incision sites: 97 urologists chose lumbar transverse incision, 202 chose dorsal oblique incision of the waist, 119 chose ventral oblique incision, 93 chose the paramedian incision, 112 chose the lower abdominal oblique incision (Gibson), 11 chose the transverse lower abdominal incision (Pfannenstiel), 7 chose the median incision of the lower abdomen, 2 chose the median incision in the upper abdomen, 15 chose axillary midline direct incision; 399 chose to cut off the muscles, and 202 chose not to. Complications: 232 urologists reported pain after 2 weeks, 369 reported no pain; 325 reported numbness after 2 weeks, 276 reported no numbness; 66 reported incisional hernia, 535 reported no hernia. 【Conclusions】 Chinese urologists tend to choose retroperitoneoscopic nephrectomy and waist incision to obtain intact specimens. Transperitoneal laparoscopic nephrectomy has a variety of incisions for intact specimens. There is no standardized incision sites to obtain intact specimens.